1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Head and Neck Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, LL; Kreutzer, DL; Mann, EA; Spiro, JD | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Head and Neck Neoplasms
Article | Year |
---|---|
Phospholipid metabolite expression by head and neck squamous cell carcinoma.
Topics: Aged; Analysis of Variance; Animals; Carcinoma, Squamous Cell; Dinoprostone; Epidermal Growth Factor; Evaluation Studies as Topic; Fibroblasts; Head and Neck Neoplasms; Humans; Immune Tolerance; Interleukin-1; Leukotriene B4; Lipopolysaccharides; Middle Aged; Neoplasm Staging; Phenotype; Platelet Activating Factor; Radioimmunoassay; Regression Analysis; Tumor Cells, Cultured | 1994 |